Lasa Supergenerics Limited

Web: lasalabs.com NSE: LASA BSE: 540702 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

7 0(1%)

Volume

31k as on 23, Jun

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

11/100

Growth Score

0/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

No. of Shares

5.01

P/E

-5.47

P/B

1.28

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

-23.5

ROCE

Profit Growth

Listing Date

21-Sep-17

Promoter Holding

53.65%

FII Holding

DII Holding

Price Chart

Price Performance

1 Week1%

1 Month8%

3 Months5%

6 Months17%

1 Year17%

YTD17%

Moving Average

5 Day SMA8

10 Day SMA7

20 Day SMA8

30 Day SMA8

50 Day SMA7

61 Day SMA8

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	9	8	8	9
Resistance 2	8	8	8	8
Resistance 1	8	7	8	8
Pivot Point	7	7	7	8
Support 1	7	7	7	7
Support 2	7	7	7	7
Support 3	6	7	7	6

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 53.65%	(0.01) 53.65%	(0.01) 53.65%	(0.01) 53.65%	(0.01) 53.65%	(0.01) 53.65%	(0.01) 53.65%	(0.01) 53.65%	(0.01) 53.65%	(0.01) 53.65%	(0.01) 53.65%	(0.01) 53.65%	(9.91) 53.65%	(0.01) 43.78%	(0.01) 43.78%	(0.01) 43.78%	(-1.21) 43.78%	(-19.51) 45.01%	(0.01) 64.47%
FIIs	(0.01) 0.00%	(0.01) 0.00%	(-0.51) 0.00%	(0.51) 0.47%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.01%	(-0.11) 0.00%	(0.11) 0.12%	(0.01) 0.01%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.41) 0.00%	(0.41) 0.40%	(-0.11) 0.00%	(0.11) 0.06%	(0.01) 0.01%
Public	46.35%	46.34%	46.35%	45.88%	46.35%	46.35%	46.32%	46.34%	46.23%	46.33%	46.34%	46.34%	46.34%	56.21%	56.21%	55.82%	56.21%	54.93%	35.52%
No. of Shareholders	27,702	28,120	28,656	28,115	27,188	27,272	27,968	27,217	27,615	27,161	27,770	28,031	28,818	28,936	29,692	30,087	27,859	24,827	23,066

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	-0.13	2.2	3.06	20.01	39.14	33.08	39.39	30.84	22.82	26.66	24.3	30.56	35.32	31.7	33.66	29	51	15.74	34.11
Sales Growth % (YoY)	-100%	-93%	-92%	-35%	72%	24%	62%	1%	-35%	-16%	-28%	6%	-31%	101%	-1%	-19.9%	31%	-70.8%	-38%
Sales Growth % (QoQ)	-105.9%	-28.1%	-84.7%	-48.9%	18.3%	-16%	27.7%	35.1%	-14.4%	9.7%	-20.5%	-13.5%	11.4%	-5.8%	16.1%	-43.1%	224%	-53.9%	-
Expenses	1.99	2.95	7.06	20.51	35.73	32.81	38.6	29.04	26.81	25.6	23.25	26.51	30.98	34.16	33.99	37	40	16.92	32.86
Operating Profit	-2.12	-0.75	-4	-0.5	3.41	0.27	0.79	1.8	-3.99	1.06	1.05	4.05	4.34	-2.46	-0.33	-8	11	-1.18	1.25
OPM %	0	-34.09	-130.72	-2.5	8.71	0.82	2.01	5.84	-17.48	3.98	4.32	13.25	12.29	-7.76	-0.98	-28	21	-7.5	3.66
Other Income	-0.42	0.02	0.01	-20.44	-21.52	8.91	1.95	0	-8.76	0	0.08	0	-18.97	0.86	-2.47	0	4	0.01	-11.88
Interest	0.13	0.11	0.12	0.03	0.11	0.47	1.24	0.87	0.56	0.44	0.56	0.37	0.41	0.43	0.84	0	0	0.01	0
Depreciation	1.31	1.57	1.57	1.57	3.9	2.8	2.81	2.79	2.66	2.68	2.68	2.65	4.17	3.09	3.09	3	4	3.59	3.45
Profit before tax	-3.98	-2.41	-5.68	-22.54	-22.12	5.91	-1.31	-1.86	-15.97	-2.06	-2.11	1.03	-19.21	-5.12	-6.73	-11	11	-4.77	-14.08
Tax %	4.77	5.81	10.04	-6.3	-35.4	7.11	146.56	46.77	-4.2	-29.61	-99.05	580.58	-21.92	-3.91	-2.08	8	-7	-1.05	-2.41
Net Profit	-4.16	-2.55	-6.25	-21.12	-14.29	5.49	-3.23	-2.73	-15.3	-1.46	-0.02	-4.95	-15	-4.92	-6.61	-12	12	-4.71	-13.74
Net Profit Growth % (QoQ)	-63.1%	59.2%	70.4%	-47.8%	-360.3%	270%	-18.3%	82.2%	-947.9%	-7200%	99.6%	67%	-204.9%	25.6%	44.9%	-200%	354.8%	65.7%	-
Net Profit Growth % (YoY)	70.9%	-146.4%	-93.5%	-673.6%	6.6%	476%	-16050%	44.8%	-2%	70.3%	99.7%	58.8%	-225%	-4.5%	51.9%	-	-	-	-
TTM Net Profit	-34.08	-44.21	-36.17	-33.15	-14.76	-15.77	-22.72	-19.51	-21.73	-21.43	-24.89	-31.48	-38.53	-11.53	-11.32	-18.45	-6.45	-18.45	0
EPS in Rs	-0.83	-0.51	-1.25	-4.22	-2.85	1.1	-0.64	-0.54	-3.05	-0.29	0	-0.99	-2.99	-1.21	-1.63	-2.97	2.98	-1.16	-3.38

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Jan 1900
Sales	25	142	104	130	137	201	167	170	244	199	0
Sales Growth %	-82%	37%	-19%	-5%	-32%	20%	-1%	-30%	23%	-	-
Expenses	32	136	102	136	120	154	137	158	202	153	0
Operating Profit	-7	6	2	-6	16	47	30	11	41	46	0
OPM %	-29	4	2	-5	12	24	18	7	17	23	0
Other Income	-21	-11	-9	-18	-8	0	0	0	3	-24	0
Interest	0	3	2	4	0	2	8	8	11	12	0
Depreciation	6	12	11	13	15	16	17	19	18	8	0
Profit before tax	-35	-19	-19	-42	-6	30	5	-16	15	2	0
Tax %	-2	-24	14	-9	-13	23	23	-25	19	-10	0
Net Profit	-34	-15	-22	-39	-5	23	4	-12	12	2	0
Net Profit Growth %	-126.7%	31.8%	43.6%	-680%	-121.7%	475%	133.3%	-200%	500%	-	-
EPS in Rs	-6.8	-2.95	-4.34	-7.71	-1.31	5.6	0.89	-5.26	5.4	0	0
Dividend Payout %	0	0	0	0	-24	4	0	0	0	0	0

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Cash from Operating Activity	-3	2	-17	9	41	14	41	40	-3
Cash from Investing Activity	8	0	11	-3	-4	-2	-7	-44	0
Cash from Financing Activity	-6	-2	-4	0	-36	-10	-33	4	0
Net Cash Flow	0	0	-10	6	1	2	0	0	-3

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016
Equity Capital	50	50	50	50	50	50	50	41	41	23	23	0.05	0.05
Reserves	0	6	34	41	47	68	108	118	101	82	94	75	0
Borrowings	10	7	2	20	22	22	20	19	48	85	107	116	0
Other Liabilities	7	8	16	36	32	24	31	29	42	69	63	37	0
Total Liabilities	66	72	102	147	151	164	209	208	232	258	287	228	0
Fixed Assets	55	58	68	105	110	119	137	143	152	162	170	119	0
CWIP	0	0	0	3	3	5	5	0	0	7	7	30	0
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	11	13	33	40	39	40	67	65	80	90	110	80	0
Total Assets	66	72	102	147	151	164	209	208	232	258	287	228	0

Delivery

#	Date	7 30% 9	Q/T 286	Del 67
1	22-Jul	7	126	73
2	21-Jul	7	159	80
3	20-Jul	7	163	98
4	17-Jul	7	345	76
5	16-Jul	7	92	74
6	15-Jul	7	113	75
7	14-Jul	7	200	68
8	13-Jul	7	104	76
9	10-Jul	8	141	62
10	9-Jul	7	202	73
11	8-Jul	7	298	54
12	7-Jul	7	235	45
13	6-Jul	7	178	82
14	3-Jul	7	191	55
15	2-Jul	7	254	74
16	1-Jul	8	254	62
17	30-Jun	8	116	70
18	29-Jun	7	170	58
19	25-Jun	8	177	69
20	24-Jun	8	122	71
21	23-Jun	7	325	62
22	22-Jun	7	219	35
23	19-Jun	8	207	54
24	18-Jun	8	161	65
25	17-Jun	8	203	76
26	16-Jun	7	237	81
27	15-Jun	7	255	62
28	12-Jun	7	290	45
29	11-Jun	7	226	83
30	10-Jun	8	145	83
31	9-Jun	8	102	59
32	8-Jun	8	258	87
33	5-Jun	8	101	84
34	4-Jun	8	214	80
35	3-Jun	8	154	95
36	2-Jun	8	279	58
37	1-Jun	8	441	71
38	29-May	8	227	82
39	27-May	8	480	99
40	26-May	8	226	88
41	25-May	8	287	82
42	22-May	8	166	71
43	21-May	8	178	76
44	20-May	8	123	63
45	19-May	8	93	85

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	36c	60L	1.70
22-Jul	35c	2c	3.95
21-Jul	37c	25L	0.68
17-Jul	37c	5L	0.14
16-Jul	37c	35L	0.94
15-Jul	37c	45L	1.22
14-Jul	37c	15L	0.41
13-Jul	37c	0	0
10-Jul	37c	50L	1.34
09-Jul	37c	50L	1.36
08-Jul	37c	25L	0.68
07-Jul	37c	10L	0.27
06-Jul	37c	1c	2.89
01-Jul	38c	75L	2.01
30-Jun	37c	70L	1.84
29-Jun	38c	45L	1.17
26-Jun	39c	1c	3.09
25-Jun	37c	40L	1.06
24-Jun	38c	0	0
23-Jun	38c	15L	0.40
22-Jun	38c	0	0
19-Jun	38c	30L	0.80
17-Jun	38c	10L	0.27
16-Jun	38c	1c	3.46
15-Jun	36c	20L	0.56
12-Jun	36c	1c	2.97
11-Jun	37c	2c	4.26
10-Jun	39c	0	0

Stock Checklist

Price is below from 52 week high low average: 64%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView